Ifosfamide-induced Fanconi syndrome with diabetes insipidus
The Korean Journal of Internal Medicine
;
: 246-249, 2014.
Artículo
en Inglés
| WPRIM
| ID: wpr-105985
ABSTRACT
Ifosfamide-induced Fanconi syndrome is a rare complication that typically occurs in young patients due to a cumulative dose of ifosfamide > 40-60 g/m2, a reduction in kidney mass, or concurrent cisplatin treatment. It is usually characterized by severe and fatal progression accompanied by type II proximal renal tubular dysfunction, as evidenced by glycosuria, proteinuria, electrolyte loss, and metabolic acidosis. Diabetes insipidus is also a rare complication of ifosfamide-induced renal disease. We herein describe a case involving a 61-year-old man who developed ifosfamide-induced Fanconi syndrome accompanied by diabetes insipidus only a few days after the first round of chemotherapy. He had no known risk factors. In addition, we briefly review the mechanisms and possible therapeutic options for this condition based on other cases in the literature. Patients who receive ifosfamide must be closely monitored for renal impairment to avoid this rare but fatal complication.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Factores de Tiempo
/
Acidosis
/
Quimioterapia Adyuvante
/
Resultado Fatal
/
Antineoplásicos Alquilantes
/
Terapia Neoadyuvante
/
Diabetes Insípida
/
Histiocitoma Fibroso Maligno
/
Síndrome de Fanconi
/
Ifosfamida
Tipo de estudio:
Factores de riesgo
Límite:
Humanos
/
Masculino
Idioma:
Inglés
Revista:
The Korean Journal of Internal Medicine
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS